Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT

Chemotherapy

Citations 1-3 of 3 total displayed.

Most recent content (1 Feb 2004):

ORIGINAL ARTICLES
Hyperthermic Isolated Limb Perfusion With Low-Dose Tumor Necrosis Factor-{alpha} and Melphalan for Bulky In-Transit Melanoma Metastases
Carlo Riccardo Rossi, Mirto Foletto, Simone Mocellin, Pierluigi Pilati, and Mario Lise
Ann. Surg. Oncol. 2004; 11: 173-177. [Abstract] [Full text] [PDF]  

Past content (since Jun 2003):

ORIGINAL ARTICLES
Hyperthermic Isolated Limb Perfusion With Low-Dose Tumor Necrosis Factor-{alpha} and Melphalan for Bulky In-Transit Melanoma Metastases
Carlo Riccardo Rossi, Mirto Foletto, Simone Mocellin, Pierluigi Pilati, and Mario Lise
Ann. Surg. Oncol. 10.1245/ASO.2004.03.019. [Abstract] [PDF]  

NEW APPROACHES TO THE TREATMENT OF HEPATIC MALIGNANCIES
Pentoxifyllin Attenuates the Systemic Inflammatory Response Induced During Isolated Limb Perfusion With Recombinant Human Tumor Necrosis Factor-{alpha} and Melphalan
Peter Hohenberger, Eicke Latz, Christoph Kettelhack, Amir-Hossein Rezaei, Ralf Schumann, and Peter M. Schlag
Ann. Surg. Oncol. 2003; 10: 562-568. [Abstract] [Full text] [PDF]  

* Collected Resources Home

* Related collections:
 Melanoma
 Chemotherapy
 Diagnosis
 Immunotherapy
 Metastases
 Pathology
 Prognostic factors
 Radiation Therapy
 Sentinel lymph node
 Surgery
 Other Melanoma


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Copyright © 2008 by the Society of Surgical Oncology.